Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2011 | B cell depletion therapy exacerbates murine primary biliary cirrhosis. | Dhirapong, A; Lleo, A; Yang, GX; Tsuneyama, K; Dunn, R; Kehry, M; Packard, TA; Cambier, JC; Liu, FT ; Lindor, K; Coppel, RL; Ansari, AA; Gershwin, ME | Hepatology 53(2), 527-535 | | | |
2006 | Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice. | Nomoto, K; Tsuneyama, K; Abdel Aziz, HO; Takahashi, H; Murai, Y; Cui, ZG; Fujimoto, M; Kato, I; Hiraga, K; Hsu, DK; Liu, FT ; Takano, Y | The Journal of pathology 210(4), 469-77 | | | |
2008 | Nonalcoholic steatohepatitis and hepatocellular carcinoma in galectin-3 knockout mice. | Nakanishi, Y; Tsuneyama, K; Nomoto, K; Fujimoto, M; Salunga, TL; Nakajima, T; Miwa, S; Murai, Y; Hayashi, S; Kato, I; Hiraga, K; Hsu, DK; Liu, FT ; Takano, Y | Hepatology research : the official journal of the Japan Society of Hepatology 38(12), 1241-1251 | | | |
2008 | Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study. | Abdel-Aziz, HO; Murai, Y; Takasaki, I; Tabuchi, Y; Zheng, HC; Nomoto, K; Takahashi, H; Tsuneyama, K; Kato, I; Hsu, DK; Liu, FT ; Hiraga, K; Takano, Y | Journal of cancer research and clinical oncology 134(7), 777-788 | | | |
2010 | Treatment of hepatocellular carcinoma with adeno-associated virus encoding interleukin-15 superagonist. | Chang, CM; Lo, CH; Shih, YM; Chen, Y; Wu, PY; Tsuneyama, K; Roffler, SR; Tao, MH | Human gene therapy 21(5), 611-621 | | | |